Silver Book Fact

Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.

Goldman, Dana P., Baoping Shang, Jayanta Bhattacharya, Alan M. Garber, Michael Hurd, Geoffrey F. Joyce, Darius N. Lakdawalla, Constantijn Panis, and Paul G. Shekelle. Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly. Health Affairs Web Exclusive Collection. 2005; 24(2). http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w5.r5v1

Reference

Title
Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly
Publication
Health Affairs Web Exclusive Collection
Publication Date
2005
Authors
Goldman, Dana P., Baoping Shang, Jayanta Bhattacharya, Alan M. Garber, Michael Hurd, Geoffrey F. Joyce, Darius N. Lakdawalla, Constantijn Panis, and Paul G. Shekelle
Volume & Issue
Volume 24, Issue 2
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Decrease in AFib hospitalization rates
    The use of practice guidelines in atrial fibrillation patients saw a decrease in rate of hospitalization from 74%to 38%.  
  • For every dollar spent on cardiovascular medical treatments, a return of $4 is realized.  
  • The use of ACE inhibitors in hypertensive patients 80 years of older was associated in this study with a 30% reduction in the rate of stroke and a 64% reduction…  
  • Because of reduced mortality rates, the number of stroke survivors who are non-institutionalized increased from 2.0 to 2.4 million between 1980 and 1991.  
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.